Zhang LY, Zhang YQ, Zeng YZ, Zhu JL, et al. TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway. Breast Cancer Res Treat 2020 May 15. pii: 10.1007/s10549-020-05673.
PMID: 32415497